Endovascular repair of extent I thoracoabdominal aneurysms with landing zone extension into the aortic arch and mesenteric portion of the abdominal aorta  by Brinster, Clayton J. et al.
From the Eastern Vascular Society
Endovascular repair of extent I thoracoabdominal
aneurysms with landing zone extension into the
aortic arch and mesenteric portion of the
abdominal aorta
Clayton J. Brinster, MD,a Wilson Y. Szeto, MD,b Joseph E. Bavaria, MD,b Edward Y. Woo, MD,a
Ronald M. Fairman, MD,a and Benjamin M. Jackson, MD,a Philadelphia, Pa
Thoracic endovascular aortic repair (TEVAR) has emerged as an alternative for patients at prohibitive risk for open
thoracic or thoracoabdominal surgery, decreasing perioperative morbidity and mortality. Aneurysms that involve both
the left subclavian artery (LSA) proximally and the celiac artery (CA) distally present a unique challenge to the use of
TEVAR. We report a series of six high-risk patients presenting with extent I thoracoabdominal aortic aneurysms who
were successfully treated with TEVAR including coverage of the LSA and the CA. (J Vasc Surg 2010;52:460-3.)Endovascular repair of isolated descending thoracic
aortic aneurysms has emerged as an alternative to open
repair in selected patients, decreasing perioperative mor-
bidity and mortality when compared to open thoracic or
thoracoabdominal approaches. Anatomically complex an-
eurysms, including those that involve the aortic arch and
mesenteric vessels or those that have short or diseased
landing zones, have complicated and limited the wide-
spread application of endovascular therapy to thoracoab-
dominal aortic aneurysms (TAAA). Several treatment mo-
dalities have emerged in the treatment of complex
aneurysms, including hybrid procedures, branched or fe-
nestrated endografting, and endograft placement with cov-
erage of aortic branches with or without revascularization.
To date, there are no dedicated case series of thoracic
endovascular aortic repair (TEVAR) to treat extent I
TAAA. We report a series of six high-risk patients present-
ing with extent I TAAA successfully treated with TEVAR
including coverage of the left subclavian artery (LSA) and
celiac artery (CA).
CASE REPORTS
Between August 2005 and April 2009, 305 patients under-
went TEVAR and were entered prospectively into a surgical data-
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460base. Six patients (2.0%; 2 men, 4 women) with extent I TAAAs
were identified retrospectively. These patients required proximal
landing zone extension into zone 2 of the aortic arch and distal
landing zone extension into the mesenteric portion of the abdom-
inal aorta, with coverage of the CA to achieve adequate aneurysmal
exclusion (Fig 1). Patients were a mean age of 76.3 years (range,
70-83 years), and the average maximum aneurysmal diameter was
6.8 cm.
Except when contraindicated in one patient by renal failure, all
patients underwent preoperative computed tomographic angiog-
raphy (CTA) to evaluate collateral circulation between the CA and
superior mesenteric artery (SMA). Three of these five had SMA to
CA collateralization through the gastroduodenal artery, one had a
replaced right hepatic artery from a patent SMA, and one had a
chronically occluded CA. Preoperative CTA showed all patients
had patent superior and inferior mesenteric arteries and internal
iliac arteries. In all cases, hepatic perfusion was verified with a
predeployment visceral aortogram and a postdeployment comple-
tion angiography.
The six patients underwent left carotid-to-LSA bypass 3 to 5
days before aortic repair. At the time of TEVAR, left brachial
sheath access was established for coil embolization of the LSA
stump proximal to the bypass and to the left vertebral artery to
maintain left upper extremity and posterior cerebral perfusion.1
The proximal landing zone in all six patients extended to zone 2 of
the aortic arch to include complete coverage of the LSA origin. All
procedures were completed under general endotracheal anesthe-
sia, and cerebrospinal fluid drains were placed in all patients. Gore
TAG (W. L. Gore and Associates, Flagstaff, Ariz) or Zenith TX2
(Cook Endovascular, Bloomington, Ind) endografts were used.
Follow-up consisted of CTA and physical examination at 1, 6,
and 12 months postoperatively and then serially every 12 months
thereafter. Imaging studies were evaluated for the presence of
endoleak, device migration, and aneurysm sac size.
Proximal sealing without evident type I proximal endoleak was
accomplished in five of the six patients (Fig 2). The average
proximal neck length was 20.0 mm. Two patients required partial
CA coverage by the distal thoracic endograft to ensure adequate
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celiac stenting were used in these two patients to maintain ante-
grade foregut perfusion. Complete occlusion of the CA was re-
quired in four patients to achieve adequate distal fixation and
aneurysmal exclusion (Fig 3). The average distal neck length was
19.2 mm. An average of 3.5 thoracic stent grafts (range, 2-6) were
used during each patient’s initial TEVAR.
There were no perioperative deaths (30 days). Two intraop-
erative complications occurred, including an external iliac artery
avulsion during device withdrawal that was repaired with open
iliofemoral bypass and a common iliac artery dissection that was
recognized and repaired intraoperatively with a covered stent graft.
No elevations were observed in postoperative white blood cell
count, serum lactate, or liver or pancreatic enzymes, and no signs
or symptoms were reported of visceral, spinal, or left upper extrem-
ity ischemia.
One patient had a persistent, distal type I endoleak that
required endovascular reintervention with deployment of a Zenith
TX2 stent graft to eliminate the endoleak (Fig 4). One patient
continued to have a small, persistent, proximal type I endoleak
despite an extensive attempt at endovascular sealing; this patient
has an asymptomatic, stable 6-cm aneurysm 14 months after
surgery. After a mean follow-up of 30.5 months, there were no
reported deaths and no reported complications of paraplegia,
visceral ischemia, spinal ischemia, type II endoleak, conversion to
open revascularization, left upper extremity ischemia, or aneurysm
rupture.
DISCUSSION
In the 15 years since Dake et al2 first reported the
successful endovascular treatment of TAAA, numerous
studies have demonstrated the safety and feasibility of this
Fig 1. Three-dimensional reconstructions of a computed tomog-
raphy angiogram using M2S software (West Lebanon, NH) show
an extent I thoracoabdominal aortic aneurysm (A) preoperatively
and (B) after thoracic endovascular aneurysm repair. Note the
landing zone extension to include coverage of the left subclavian
artery (white arrow) proximally and the celiac artery (yellow arrow)
distally.technique, with low reported morbidity, mortality, andintermediate results compared with open surgical repair.3-5
Complete endovascular exclusion of TAAA requires ade-
quate fixation and sealing, and anatomically inadequate
proximal and distal sealing zones are the most common
prohibitive factors to endovascular repair in these patients.6
Endovascular exclusion of the LSA origin to extend the
proximal landing zone during TEVAR has been reported
and is well-tolerated in selected patients.7,8 The available
data on the necessity of revascularization when stent graft
coverage of the LSA is required suggest that patients with
previous extensive aortic coverage, previous AAA repair, or
compromised internal iliac artery circulation may benefit
from LSA revascularization to reduce paraplegia risk.9-12
Our approach in most patients requiring coverage of the
LSA origin is a staged left common carotid-to-LSA bypass
3 to 5 days before TEVAR with subsequent coil emboliza-
tion of the LSA stump at the time of thoracic stent graft
placement.7 When long-segment aortic coverage is re-
quired during TEVAR as in patients with extent I TAAA,
we consider prophylactic LSA revascularization essential to
avoid spinal cord ischemia.
Several recent case series have evaluated CA coverage
during TEVAR. Vaddineni et al13 reported seven patients
who underwent planned CA coverage to achieve adequate
distal sealing during endovascular repair of descending
Fig 2. A, A predeployment aortogram shows the proximal extent
of the thoracoabdominal aortic aneurysm. B, The postdeployment
aortogram shows landing zone extension into the aortic arch with
a patent left subclavian artery (LSA) bypass (arrow). C, The
completion angiogram after thoracic endovascular aneurysm repair
and proximal LSA coiling shows aneurysmal exclusion without
endoleak; note the patent LSA bypass and antegrade distal LSA
perfusion (arrow). D, The proximal LSA has been coil embolized
through brachial artery access to prevent type II endoleak.thoracic aneurysms with no deaths and no ischemic com-
angio
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with CA coverage, Leon et al14 reported more concerning
results in the 16 of 19 patients who did not undergo
mesenteric revascularization: 19 complications were ob-
served, with 3 deaths and 2 patients with postoperative
paraplegia. The authors concluded that complications oc-
curred more often without revascularization and that pre-
operative angiography and selective SMA angiography did
not predict postoperative outcome.
The current case series reviews six patients who under-
went both LSA and CA coverage to accomplish successful
TEVAR of extent I TAAA. All patients underwent intraop-
erative completion angiography after stent graft deploy-
ment to verify SMA-to-CA collateralization and resultant
liver perfusion. Although no patients exhibited signs of
mesenteric ischemia postoperatively, our predetermined
treatment algorithm in such cases is for immediate open
Fig 3. A, The distal extent of the thoracoabdominal ao
An early-phase postdeployment lateral angiogram shows c
(SMA) perfusion. C, A late-phase postdeployment latera
retrograde filling of the celiac axis. D, Collateral filling o
anteroposterior view of the postdeployment completion
Fig 4. A, A computed tomography angiogram recons
distal type I endoleak (arrow) after the initial thoracic en
B, Antegrade superior mesenteric artery perfusion (black
a distal type I endoleak (white arrow) in the patient from P
exclusion after reintervention. D, An M2S reconstructio
note the absence of endoleak.surgical revascularization.Prior reports of hybrid approaches to TAAA repair have
concentrated on visceral and arch debranching before
TEVAR in patients with heterogeneous aneurysmal anat-
omy, including extent II, III, and IV TAAA, with few
reported cases of extent I TAAA management. Patel et al15
reported a series of 23 high-risk patients undergoing hybrid
TAAA repair, including 9 with extent I TAAA. Four of
these nine patients had persistent postoperative endoleaks,
and four had serious complications or died in the perioper-
ative period. In the largest series of this type, Black et al16
reported 29 patients undergoing hybrid procedures for
TAAA. Three had extent I TAAA, and persistent postoper-
ative endoleak developed in two of these three after proxi-
mal landing zone extension into the aortic arch. Using
another approach, Greenberg et al17 managed extent I
TAAA with branched endografts, reporting a 7% mortality
and a 10% risk of spinal cord ischemia. These results from
neurysm is shown in this predeployment angiogram. B,
artery coverage and antegrade superior mesenteric artery
ogram shows antegrade SMA perfusion and subsequent
hepatic and splenic arteries (arrows) can be seen in this
gram.
on using M2S software (West Lebanon, NH) shows a
scular aneurysm repair, including celiac artery coverage.
) is evident in this angiogram, which also demonstrates
A.C, An angiogram shows distal sealing and aneurysmal
a postreintervention computed tomography angiogramrtic a
eliac
l angi
f thetructi
dova
arrow
anel
n ofexperienced, high-volume centers indicate the highly com-
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in high-risk patients.
This case series details initial success using TEVAR in
the management of extent I TAAA in six patients, with
no deaths and no paraplegia after an average follow-up of
30.5 months. Two of the six patients required endovas-
cular reintervention to treat postoperative type I en-
doleaks, and one of these two endoleaks persisted despite
reintervention. The reintervention rate of 33% reinforces
the challenging nature of endovascular repair of these
complex aneurysms in patients deemed unfit for tradi-
tional surgical approaches.
Open repair of extent I TAAA is marked by an overall
5% to 10% risk of paraplegia and a 30-day mortality rate of
5% to 20% in the most successful series from high-volume
centers.18-20 Results from the largest recent series of hybrid
approaches to TAAA indicate paraplegia rates of 0% to 9%
and 30-day mortality of 0% to 21% with various tech-
niques.15,16 Given these results, the approach described
here to manage extent I TAAAmay be beneficial in patients
with severe comorbidities and anatomic features that allow
coverage of LSA and CA during TEVAR.
CONCLUSION
This preliminary series suggests that TEVAR can be
used judiciously in the treatment of extent I TAAA as an
alternative to open or hybrid repair in high-risk patients,
and that landing zone extension to include coverage of the
LSA andCA to achieve aneurysmal exclusion is safe in select
patients. Elective LSA revascularization and subsequent
coil embolization are useful adjuncts to reduce the risk of
paraplegia and endoleak and to maintain left upper extrem-
ity perfusion. Mesenteric and hepatic ischemia were not
seen after CA coverage.
REFERENCES
1. Woo EY, Bavaria JE, Pochettino A, Gleason TG, Woo YJ, Velazquez
OC, et al. Techniques for preserving vertebral artery perfusion during
thoracic aortic stent grafting requiring aortic arch landing. Vasc Endo-
vascular Surg 2006;40:367-73.
2. Dake MD, Miller DC, Semba CP, Mitchell RS, Walker PJ, Liddell RP.
Transluminal placement of endovascular stent-grafts for the treatment
of descending thoracic aortic aneurysms. N Engl J Med 1994;331:
1729-34.
3. Ellozy SH, Carroccio A, Minor M, Jacobs T, Chae K, Cha A, et al.
Challenges of endovascular tube graft repair of thoracic aortic aneu-
rysm: midterm follow-up and lessons learned. J Vasc Surg 2003;38:
676-83.
4. Cambria RP, Brewster DC, Lauterbach SR, Kaufman JL, Geller S, Fan
CM, et al. Evolving experience with thoracic aortic stent graft repair. J
Vasc Surg 2002;35:1129-36.5. Greenberg RK, O’Neill S, Walker E, Haddad F, Lyden SP, Svensson
LG, et al. Endovascular repair of thoracic aortic lesions with the Zenith
TX1 and TX2 thoracic grafts: intermediate-term results. J Vasc Surg
2005;41:589-96.
6. Jackson BM, Carpenter JP, Fairman RM, Moser GW, Pochettino A,
Woo EY, et al. Anatomic exclusion from endovascular repair of thoracic
aortic aneurysm. J Vasc Surg 2007;45:662-6.
7. Woo EY, Carpenter JP, Jackson BM, Pochettino A, Bavaria JE, Szeto
WY, et al. Left subclavian artery coverage during thoracic endovascular
aortic repair: a single-center experience. J Vasc Surg 2008;48:555-60.
8. Peterson BG, Eskandari MK, Gleason TG, Morasch MD. Utility of left
subclavian artery revascularization in association with endoluminal re-
pair of acute and chronic thoracic aortic pathology. J Vasc Surg 2006;
43:433-9.
9. Morales JP, Greenberg RK, Morales CA, Cury M, Hernandez AV,
Lyden SP, et al. Thoracic aortic lesions treated with the zenith TX1 and
TX2 thoracic devices: intermediate- and long-term outcomes. J Vasc
Surg 2008;48:54-63.
10. Noor N, Sadat U, Hayes PD, Thompson MM, Boyle JR. Management
of the left subclavian artery during endovascular repair of the thoracic
aorta. J Endovasc Ther 2008;15:168-76.
11. GawendaM, Brunkwall J. When is it safe to cover the left subclavian and
celiac arteries. part I: left subclavian artery. J Cardiovasc Surg (Torino)
2008;49:471-7.
12. Riesenman PJ, Farber MA, Mendes RR, MarstonWA, Fulton JJ, Keagy
BA. Coverage of the left subclavian artery during thoracic endovascular
aortic repair. J Vasc Surg 2007;45:90-4; discussion 94-5.
13. Vaddineni SK, Taylor SM, PattersonMA, JordanWD Jr. Outcome after
celiac artery coverage during endovascular thoracic aortic aneurysm
repair: preliminary results. J Vasc Surg 2007;45:467-71.
14. Leon LR Jr,Mills JL Sr, JordanW,MoraschMM,KovacsM, Becker GJ,
et al. The risks of celiac artery coverage during endoluminal repair of
thoracic and thoracoabdominal aortic aneurysms. Vasc Endovascular
Surg 2009;43:51-60.
15. Patel HJ, Williams DM, Upchurch GR Jr, Shillingford MS, Dasika NL,
Proctor MC, et al. Long-term results from a 12-year experience with
endovascular therapy for thoracic aortic disease. Ann Thorac Surg
2006;82:2147-53.
16. Black SA, Wolfe JH, Clark M, Hamady M, Cheshire NJ, Jenkins MP.
Complex thoracoabdominal aortic aneurysms: Endovascular exclusion
with visceral revascularization. J Vasc Surg 2006;43:1081-9; discussion
1089.
17. Greenberg RK, LuQ, Roselli EE, Svensson LG,MoonMC,Hernandez
AV, et al. Contemporary analysis of descending thoracic and thoraco-
abdominal aneurysm repair: a comparison of endovascular and open
techniques. Circulation 2008;118:808-17.
18. Coselli JS, Bozinovski J, LeMaire SA. Open surgical repair of 2286
thoracoabdominal aortic aneurysms. Ann Thorac Surg 2007;83:
S862-4; discussion S890-2.
19. Schepens MA, Heijmen RH, Ranschaert W, Sonker U, Morshuis WJ.
Thoracoabdominal aortic aneurysm repair: Results of conventional
open surgery. Eur J Vasc Endovasc Surg 2009;37:640-5.
20. Rigberg DA, McGory ML, Zingmond DS, Maggard MA, Agustin M,
Lawrence PF, et al. Thirty-day mortality statistics underestimate the risk
of repair of thoracoabdominal aortic aneurysms: a statewide experience.
J Vasc Surg 2006;43:217-22; discussion 223.Submitted Feb 9, 2010; accepted Mar 5, 2010.
